Commerzbank Aktiengesellschaft Biogen Inc. Transaction History

Commerzbank Aktiengesellschaft

$3.75 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 21, 2020	SELL	$258.66 - $342.55 $1.21 Million - $1.6 Million	-4,670 Closed	0 $0
Q1 2020 Oct 03, 2024	BUY	$268.85 - $341.04 $1.26 Million - $1.59 Million	4,670 New	4,670 $1.48 Million
Q1 2020 Apr 29, 2020	SELL	$268.85 - $341.04 $8.35 Million - $10.6 Million	-31,065 Reduced 86.93%	4,670 $1.48 Million
Q4 2019 Oct 03, 2024	BUY	$220.06 - $304.07 $7.86 Million - $10.9 Million	35,735 New	35,735 $10.6 Million
Q4 2019 Jan 17, 2020	SELL	$220.06 - $304.07 $16.1 Million - $22.2 Million	-73,110 Reduced 67.17%	35,735 $10.6 Million
Q3 2019 Oct 03, 2024	BUY	$217.44 - $243.88 $23.7 Million - $26.5 Million	108,845 New	108,845 $25.3 Million
Q3 2019 Oct 17, 2019	BUY	$217.44 - $243.88 $356,384 - $399,719	1,639 Added 1.53%	108,845 $25.3 Million
Q2 2019 Oct 03, 2024	BUY	$219.29 - $241.72 $23.5 Million - $25.9 Million	107,206 New	107,206 $25.1 Million
Q2 2019 Jul 23, 2019	BUY	$219.29 - $241.72 $4.38 Million - $4.83 Million	19,975 Added 22.9%	107,206 $25.1 Million
Q1 2019 Oct 03, 2024	BUY	$216.71 - $338.96 $18.9 Million - $29.6 Million	87,231 New	87,231 $20.6 Million
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $10.4 Million - $16.3 Million	-47,991 Reduced 35.49%	87,231 $20.6 Million
Q4 2018 Oct 03, 2024	BUY	$278.5 - $352.75 $37.7 Million - $47.7 Million	135,222 New	135,222 $40.7 Million
Q4 2018 Feb 06, 2019	BUY	$278.5 - $352.75 $1.56 Million - $1.97 Million	5,587 Added 4.31%	135,222 $40.7 Million
Q3 2018 Oct 04, 2024	BUY	$293.51 - $383.83 $38 Million - $49.8 Million	129,635 New	129,635 $45.8 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $5.8 Million - $7.58 Million	19,748 Added 17.97%	129,635 $45.8 Million
Q2 2018 Oct 04, 2024	BUY	$257.52 - $306.91 $28.3 Million - $33.7 Million	109,887 New	109,887 $31.9 Million
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $891,019 - $1.06 Million	3,460 Added 3.25%	109,887 $31.9 Million
Q1 2018 Oct 04, 2024	BUY	$260.13 - $367.91 $2.97 Million - $4.2 Million	11,404 Added 12.0%	106,427 $29.1 Million
Q1 2018 May 01, 2018	BUY	$260.13 - $367.91 $2.97 Million - $4.2 Million	11,404 Added 12.0%	106,427 $29.1 Million
Q4 2017 Oct 04, 2024	BUY	$307.64 - $344.58 $29.2 Million - $32.7 Million	95,023 New	95,023 $30.3 Million
Q4 2017 Jan 26, 2018	BUY	$307.64 - $344.58 $881,388 - $987,221	2,865 Added 3.11%	95,023 $30.3 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $4.99 Million - $5.85 Million	17,746 Added 23.85%	92,158 $28.9 Million
Q2 2017 Aug 09, 2017	BUY	N/A	74,412	74,412 $20.2 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.44 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.39 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.13 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.08 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$752 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.

Account